Reduction Analysis Calculator

Compare within-subject, sequential analysis, and Bayesian adaptive designs against standard parallel-group studies to minimize animal use while maintaining statistical power.

Animal Welfare & 3RsSample SizeClient-Side

Try it out

Load example reduction analysis calculator data to see the full workflow

Baseline Study Design

Alternative Designs to Evaluate

Typical range: 0.3–0.7 for behavioral measures

1–8 interim looks using O'Brien-Fleming boundaries

Typical: 0.6–0.9

Reduction Analysis

Baseline Animals
50
Best Alternative
26
Animals Saved
24 (48%)
DesignAnimalsSavedReductionFeasibleNotes
Baseline (Parallel-Group)50YesReference design
Within-Subject (Repeated Measures)262448%YesRepeated-measures correlation r = 0.5 reduces within-group SD by 29%.
Sequential Analysis (Group Sequential)44612%YesO'Brien-Fleming with 2 interim looks. Max N = 52, expected N = 44 (under H₁).
Bayesian Adaptive371326%YesBayesian adaptive with prior P(effect) = 0.6, expected stopping at 75% enrollment.

Recommendation

The Within-Subject (Repeated Measures) offers the greatest reduction, saving 24 animals (48%) compared to the standard parallel-group design while maintaining the same statistical power.

  • IACUC protocol preparation — documenting reduction strategies
  • Grant applications — justifying proposed animal numbers
  • Study design optimization — comparing alternative designs
  • Annual 3Rs reporting for institutional compliance

Don't use for

  • Formal power analysis for grant submission (use G*Power or dedicated software)
  • Multi-factor or complex hierarchical designs
  • Studies with no alternative to parallel-group design

Sample Size Reduction Strategies for Animal Studies

The Reduction principle of the 3Rs requires researchers to demonstrate that they have considered and, where possible, implemented strategies to minimize animal use. Key approaches:

Within-subject designs: When endpoints are non-terminal (e.g., behavioral tests, blood draws, imaging), each animal can serve as its own control. The within-subject correlation (r) reduces the effective variance by a factor of (1 − r), directly lowering sample size requirements.
Group sequential designs: Planned interim analyses using O'Brien-Fleming alpha-spending boundaries allow early stopping when treatment effects are clear. The maximum sample size increases only 2–6% over fixed designs, but the expected sample size under the alternative hypothesis drops 15–30%.
Bayesian adaptive designs: Incorporating prior information via Bayesian methods can reduce sample sizes when reliable pilot data exists. Adaptive stopping rules allow enrollment to cease when posterior probability thresholds are met.
Effect size optimization: Pilot studies to estimate variance more accurately, training to reduce measurement error, and using validated primary endpoints all contribute to larger effective effect sizes, reducing required sample sizes.

Frequently Asked Questions